Sachi Bioworks, Inc.
Erie, CO Doing business as Sachi Bioworks Inc. Sachi Bioworks, Inc.
- UEI
- NTKPGKZLXPC1
- CAGE
- 8L8S8
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3000 Airport Dr Unit 201, Erie, CO 80516, USA
- Website
- sachibio.com
- Founded
- 2019
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel brain-penetrant RNA therapeutic for treatment of amyotrophic lateral sclerosis | Defense Health Agency | $1,979,313 | |
| Sbir phase III - reversing immune dysregulation during spaceflight missions | Shared Services Center | $2,234,767 | |
| E014042 sbir phase III rapid, low-cost nanoligomertm based drug-discovery in space | Shared Services Center | $5,445,236 | |
| Novel nanoligomer-based therapeutics for inflammatory bowel disease - project summary-sachi bioworks has developed a… | National Institute of Diabetes and Digestive and Kidney Diseases | $1,094,022 | |
| E014042 sbir phase i rapid, low-cost drug-discovery in space | Shared Services Center | $166,498 |
About Sachi Bioworks, Inc.
Sachi Bioworks, Inc. is a self-certified small disadvantaged business located in Erie, Colorado, specializing in advanced biotechnology research and development with a focus on innovative drug discovery platforms. The company leverages its proprietary NanoligomerTM technology to develop novel therapeutic solutions across multiple scientific domains, including space-related medical research, immune system engineering, and targeted genetic interventions. Their core competency involves creating rapid, low-cost drug discovery processes that can be applied in complex environments such as microgravity conditions and specialized medical research contexts.
The company has secured multiple federal contract awards primarily from NASA under the Small Business Innovation Research (SBIR) program, concentrating on critical research related to immune system dysregulation during spaceflight missions. These contracts, totaling approximately $6,771,477, have progressively advanced through SBIR Phase I, II, and III stages, focusing on developing innovative drug discovery methodologies that can be conducted in space environments. Each contract was set aside for small businesses and involved developing rapid, low-cost technological approaches to address immune system challenges faced by astronauts during long-duration space travel, utilizing Sachi Bioworks' unique NanoligomerTM biotechnology platform.
Regarding federal grant awards, Sachi Bioworks has received notable funding from the Defense Health Agency and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). A significant $1,979,313 grant from the Defense Health Agency, awarded in April 2025, supports the development of a brain-penetrant RNA therapeutic for amyotrophic lateral sclerosis (ALS) treatment. Additionally, a $131,498 NIDDK grant focused on developing nanoligomer-based therapeutics for inflammatory bowel disease, demonstrating the company's ability to apply its technological platform to diverse medical research challenges. These grants underscore Sachi Bioworks' commitment to advancing innovative therapeutic solutions across multiple complex medical domains, leveraging their proprietary NanoligomerTM technology to address significant health challenges.
Quick answers
What is Sachi Bioworks, Inc.'s UEI?
Sachi Bioworks, Inc.'s Unique Entity ID (UEI) in SAM.gov is NTKPGKZLXPC1.
What is Sachi Bioworks, Inc.'s CAGE code?
Sachi Bioworks, Inc.'s CAGE code is 8L8S8.
What is Sachi Bioworks, Inc.'s primary NAICS code?
Sachi Bioworks, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Sachi Bioworks, Inc. located?
Sachi Bioworks, Inc.'s physical address in SAM.gov is 3000 Airport Dr Unit 201, Erie, CO 80516, USA.
Is Sachi Bioworks, Inc. registered in SAM.gov?
Yes. Sachi Bioworks, Inc.'s SAM.gov registration is active through July 10, 2027.
What is Sachi Bioworks, Inc.'s most recent federal award?
Sachi Bioworks, Inc.'s most recent federal grant award is Novel brain-penetrant RNA therapeutic for treatment of amyotrophic lateral sclerosis (HT94252510181), from Defense Health Agency, on April 1, 2025.
On GovTribe
See Sachi Bioworks, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors